MECP2 and Rett syndrome: It has been previously demonstrated that plasma treatment from young to aged mice increases neuronal plasticity [49], probably by delivering increased levels of neurotrophic factors like BDNF [62], whose circulating levels are decreased in both RTT patients and Mecp2-/y mice.